News

Data show women with AMI exhibited a more adverse cardiac risk factor profile and were more socially vulnerable than men in the US compared to Canada.

Triamcinolone acetonide injectable suspension has been approved for administration via the suprachoroidal pathway—located in the back of the eye.

The rates of adverse events was similar across all 4 indications in comparison to the placebo group.

Hypertension rates were low in both ulcerative colitis and multiple sclerosis patients treated with ozanimod, regardless of concurrent SNRI/SSRI use.

Data show In youth with obesity, but not healthy weight, visceral fat was positively associated with PWV and was predictive of PWV beyond BMI and waist circumference.

Combined therapies such as ultraviolet light and tab methotrexate were deemed effective in the management of vitiligo.

In the full interview with Dr. Fasipe, she challenges healthcare professionals to step up their understanding of sickle cell disease and the complications that patients are facing when they seek help.

Investigators recommended a treatment course of at least 1-2 months with medium strength to potent topical corticosteroids should be considered before dupilumab discontinuation in affected children and adolescents.

The novel PDS implant will allow patients with retina disease to receive continuous anti-VEGF formulation for up to 6 months between refills.

In older patients receiving medication intensification, no differences were seen in the risk of severe hyperglycemia, severe hypoglycemia, or death at 1 year.

Though high-dose ultraviolet therapy was also effective, investigators were concerned with the potential long-term adverse events.

This represents the first biologic to show positive phase 3 results in prurigo nodularis.

Lactate dehydrogenase levels were significantly higher in patients with Influenza A.

The REVEAL Lite 2 risk assessment tool confirmed that treatment with the agonist improved risk profile and long-term outcomes of patients with pulmonary arterial hypertension.

Dr. Glanzman presented during AAP 2021 about executive function impairments in patients with ADHD.

Over the 5-year follow-up period, 94 of 170 participants had 1 or more long lapses in care, while 50 participants had short lapses only.

Many of the measures put in place because of COVID-19 have also helped to reduce the rates of C difficile infections.

There was a higher risk of type 2 diabetes in patients with fibrosis stage F4 compared to patients with stage F0 or F2.

In 1774 estimated discharges where a hospital region in the US had been indicated, 35.9% were diagnosed in the West and 32.3% in the South.

The risk of developing atopic dermatitis due to these combined effects is especially prevalent in infant boys with high maternal anxiety.

The indication makes 6 to 11-year-old children with eosinophilic biomarkers or corticosteroid dependency eligible for the biologic add-on therapy.

The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.

Investigators believe the new instrument could be generalized to other chronic inflammatory skin diseases in future studies.

Students with ADHD have struggled with virtual schooling during the COVID-19 pandemic.

Investigators propose oral treprostinil be considered when treating patients with pulmonary arterial hypertension.

ILD is a very broad category of chronic lung conditions with considerable nuance. Glassberg joins to discuss the roles of biomarkers, biopsies and drugs, as well as multidisciplinary clinics and stem cell therapy.

Recent studies have shown the majority of potential FMT donors are ultimately rejected.

A sickle cell patient takes center stage to share with healthcare providers what it’s truly like living through a vaso-occlusive crisis.

Patients treated with the monoclonal antibody had increased incidences of conjunctivitis, though many of these incidences were considered mild and were resolved by the end of the study.

The mean IR of first registered DFU was 2.5 per 1000 person-years for patients with T2D and 1.6 per 1000 person-years for patients with T1D.